CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Quality Chemical Industries Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Quality Chemical Industries Ltd
Plot 1-7
1st Ring Road, Luzira Industrial Park,
Phone: +256 312341100p:+256 312341100 KAMPALA, Uganda Ticker: CQCILCQCIL
Business Summary
Quality Chemical Industries Limited is a pharmaceutical manufacturing company. The Company’s principal activity is the manufacturing and selling of pharmaceutical drugs, with emphasis on antiretroviral (ARVs) and Artemisinin-based Combination Therapy (ACTs or anti-malarial drugs). It is focused on advancing wellness and is the producer of WHO pre-qualified human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome and Malaria treatments in the region. Its products include HIV/AIDS, Malaria, Anti-emetics, Anti-infectives, Hepatitis, Hypertension, Reproductive Health, and Tuberculosis. Anti-infectives are essential medicines designed to prevent and treat infections. This category encompasses antibacterials, antivirals, antifungals and antiparasitic medications. Its HIV product portfolio includes Lamivudine/Tenofovir Disoproxil Fumarate Tablets; Dolutegravir (as Sodium), Lamivudine & Tenofovir Tablets; Efavirenz, Lamivudine & Tenofovir Disoproxil Fumarate Tablets, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman, Co-Founder EmmanuelKatongole 57 11/1/2013
Chief Executive Officer, Executive Director Nevin J.Bradford 62 11/26/2013
Chief Commercial Officer, Executive Director, Co-Founder George W.Baguma 59
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 320 (As of 3/31/2021)
Outstanding Shares: 3,651,909,200 (As of 3/31/2024)
Shareholders: 2,581
Stock Exchange: UGA
Fax Number: +256 414221319


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024